Show simple item record

dc.contributor.authorMathur, H
dc.contributor.authorField, D
dc.contributor.authorUpton, Mathew
dc.contributor.authorCotter, PD
dc.date.accessioned2021-07-26T16:20:54Z
dc.date.issued2021-06-08
dc.identifier.issn1664-302X
dc.identifier.issn1664-302X
dc.identifier.otherARTN 695081
dc.identifier.urihttp://hdl.handle.net/10026.1/17376
dc.description.abstract

This Research Topic concerns bacteriocins and others RiPPs (Ribosomally synthesized and Post-translationally modified Peptides) as alternatives to antibiotics. Due to the increasing problem of antibiotic resistance globally, there is a pressing need to source such alternative antimicrobials. Here, in this editorial, we summarize the key papers that were published as part of this Research Topic, which consisted of a diverse range of research as well as review articles, pertaining to several different bacteriocins and RiPPs.

dc.format.extent695081-
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.language.isoen
dc.publisherFrontiers Media
dc.subjectbacteriocins
dc.subjectRiPPs
dc.subjectantimicrobials
dc.subjectantimicrobial resistance
dc.subjectgenetic engineering
dc.titleEditorial: Bacteriocins and Other Ribosomally Synthesised and Post-translationally Modified Peptides (RiPPs) as Alternatives to Antibiotics
dc.typejournal-article
dc.typeEditorial
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000664519700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.volume12
plymouth.publication-statusPublished online
plymouth.journalFrontiers in Microbiology
dc.identifier.doi10.3389/fmicb.2021.695081
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeSwitzerland
dcterms.dateAccepted2021-05-10
dc.rights.embargodate2021-7-28
dc.identifier.eissn1664-302X
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.3389/fmicb.2021.695081
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2021-06-08
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV